First quarter report Q1-2022 - preparing for the pivotal trial
Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 January – 31 March 2022. The first quarter report is available as an attached document to this press release and on www.cessatech.com under Investor/Filings & Reports. The company is progressing with planned activities: Recruitment of trial 0206 is nearly complete (a trial to investigate the pharmacokinetics in children aged 1-17 undergoing elective surgical procedures) and we are currently finalising the preparation for the initiation of our pivotal trial with CT001 (0205). We anticipate trial 0205 to